logo
Sign in

AXGN Stock Price, Chart, Stats & News

2.39B
Market cap
Current P/E
384.62x
Forward P/E

AXGN chart

1M
3M
1Y
5Y
Loading chart...

Fundamentals

Gross margin
74.31%
Operating margin
-3.49%
Pretax margin
-6.97%
Net margin
-6.97%
Effective tax rate
ROA
-7.08%
ROE
-13.44%
D/E
0.15x
Interest coverage ratio
-0.49x

AXGN valuation

P/E
P/S
7.21x
P/B
11.39x
P/CF
1807.82x
P/FCF
-495.23x
P/OCF
1807.82x
PEG
0.15x
EV multiple
185.82x

About

AxoGen, Inc., along with its subsidiaries, specializes in creating and distributing medical devices for the surgical repair of injured or severed peripheral nerves. Their comprehensive product portfolio offers several innovative solutions. The Avance Nerve Graft is a ready-to-use, biologically active human nerve allograft designed to bridge gaps in severed nerves.

Similar securities

Based on sector and market capitalization

Report issue